We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
376
Labcorp
LH
$24.3B
$10K 0.01%
+74
New +$9.78K
PCG icon
377
PG&E
PCG
$47.9B
$10K 0.01%
214
-79
-27% -$4.42K
PKG icon
378
Packaging Corp of America
PKG
$22B
$10K 0.01%
81
-124
-60% -$14.4K
POOL icon
379
Pool Corp
POOL
$6.66B
$10K 0.01%
78
+39
+100% +$4.74K
RF icon
380
Regions Financial
RF
$26.3B
$10K 0.01%
+592
New +$9.47K
SLG icon
381
SL Green Realty
SLG
$3.92B
$10K 0.01%
+102
New +$9.93K
WBD icon
382
Warner Bros
WBD
$65.9B
$10K 0.01%
445
+423
+1,923% +$8.26K
DNB
383
DELISTED
Dun & Bradstreet
DNB
$10K 0.01%
81
+51
+170% +$6.05K
ALB icon
384
Albemarle
ALB
$13.7B
$9K 0.01%
+69
New +$9.36K
GE icon
385
GE Aerospace
GE
$368B
$9K 0.01%
109
+9
+9% +$859
RYN icon
386
Rayonier
RYN
$6.49B
$9K 0.01%
+326
New +$9.05K
SON icon
387
Sonoco
SON
$5.71B
$9K 0.01%
171
-127
-43% -$6.65K
VEEV icon
388
Veeva Systems
VEEV
$30.3B
$9K 0.01%
169
+111
+191% +$6.54K
WTM icon
389
White Mountains Insurance
WTM
$5.47B
$9K 0.01%
11
-312
-97% -$273K
CBSH icon
390
Commerce Bancshares
CBSH
$8.55B
$8K 0.01%
201
-91
-31% -$3.39K
CFG icon
391
Citizens Financial Group
CFG
$30.4B
$8K 0.01%
+190
New +$7.43K
CPB icon
392
Campbell Soup
CPB
$6.47B
$8K 0.01%
+172
New +$8.18K
DAL icon
393
Delta Air Lines
DAL
$56.1B
$8K 0.01%
147
+132
+880% +$6.9K
EBAY icon
394
eBay
EBAY
$48.5B
$8K 0.01%
211
-207
-50% -$7.68K
IEX icon
395
IDEX
IEX
$16.5B
$8K 0.01%
+63
New +$8.11K
INCY icon
396
Incyte
INCY
$23.6B
$8K 0.01%
+80
New +$8.36K
KLAC icon
397
KLA
KLAC
$279B
$8K 0.01%
+770
New +$8.12K
MD icon
398
Pediatrix Medical
MD
$2.16B
$8K 0.01%
149
-6,241
-98% -$294K
ORCL icon
399
Oracle
ORCL
$339B
$8K 0.01%
173
-5,915
-97% -$290K
PCAR icon
400
PACCAR
PCAR
$70.4B
$8K 0.01%
164
-121
-42% -$5.72K
14 15
16
17 18

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.